1. Division of Advanced Therapies, National Institute for Biological Standards and Control (NIBSC), Medicines and Health Products Regulatory Agency (MHRA), South Mimms, United Kingdom.
2. Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany.